PDS Biotechnology Corporation

PDSB | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.91

+$0.07 (+8.09%)

At close: Sep 22, 2026, 4:00 PM ET

$0.90

-$0.01 (-0.85%)

After-hours: Sep 22, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $47.08M

Enterprise Value $-16.36B

Beta 1.45

Average Volume 707.28K

Shares Outstanding (Diluted) 55.5M

Shares Change YoY 36.96%

Institutional Ownership 9.09%

Exchange NASDAQ

ISIN US70465T1079

Price Performance

Price Change 1M 281.8%

Price Change 3M -7.9%

Price Change 6M 32.4%

Price Change YTD 0.8%

Price Change 1Y -22.2%

Price Change 3Y -83.9%

Price Change 5Y -94.9%

1M CAGR (ann.) 8.6%

1Y CAGR (ann.) -26.8%

5Y CAGR (ann.) -43.8%

All-Time CAGR -39.8%

Valuation

PE Ratio -1.25

Forward PE N/A

PEG Ratio -0.03

Forward PEG 0.04

PS Ratio N/A

Forward PS 2.00

PB Ratio 0.01

P/FCF Ratio -0.01

P/Adj. FCF Ratio -0.01

P/OCF Ratio -2.80

EV/Sales N/A

EV/EBIT 757.37

EV/EBITDA 2.50

EV/FCF 3.73

Earnings Yield -79.8%

FCF Yield -9325.2%

Adj. FCF Yield -7972.5%

Financial Health

Net Cash $16.41B

Total Debt $5.26B

Cash & Short-Term Investments $21.66B

Total Assets $24.66B

Current Ratio 0.57

Quick Ratio 0.57

Debt / Equity Ratio -1.22

Debt / EBITDA -0.80

Debt / FCF -1.20

OCF / Debt -0.84

Interest Coverage -4.18

Altman Z-Score -12.71

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -14.5%

Returns

Return on Assets -382.3%

Return on Equity -708.2%

Return on Invested Capital -3550.4%

Return on Capital Employed 779.6%

Return on Tangible Assets -382.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 34.7%

EPS CAGR 5Y 8.1%

EPS CAGR 10Y 40.1%

FCF CAGR 3Y -146.8%

FCF CAGR 5Y -97.2%

FCF CAGR 10Y -51.3%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y 58.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.11

EPS Growth Est (next Q) -42.1%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $9

Price Target Upside 971.4%

Cash Flow

Operating Cash Flow $-4.39B

Free Cash Flow $-4.39B

Adj. Free Cash Flow $-3.75B

FCF Per Share -$0.30

OCF Per Share -$0.30

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-6.54B

EBITDA $-6.54B

Net Income $-7.38B

EPS (Diluted) -$0.67

Revenue / Employee N/A

Profit / Employee $-351.19M

Employees 21